SECURITIES AND EXCHANGE COMMISSION

                          Washington, D.C.  20549

                                 FORM 8-K

                              CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act


                             March 7, 2006
                             ----------------
                              Date of Report
                    (Date of earliest event reported)


                          Reflect Scientific, Inc.
                          ------------------------
           (Exact name of registrant as specified in its charter)



    UTAH                        000-31377                      87-0642556
    -----                       ---------                      ----------
(State or other           (Commission File Number)            (IRS Employer
jurisdiction of                                            Identification No.)
incorporation)


                           970 Terra Bella Avenue
                       Mountain View, California 94043
                       -------------------------------
                   (Address of Principal Executive Offices)

                               (650) 960-0300
                               --------------
                       (Registrant's Telephone Number)

                                    N/A
                                    ---
        (Former Name or Former Address if changed Since Last Report)



     Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of
the following provisions (see general instruction A.2. below):

     [ ] Written communications pursuant to Rule 425 under the Securities Act
         (17 CFR 230.425)

     [ ] Soliciting material pursuant to Rule 14-a-12 under the Exchange Act
         (17 CFR 240.14a-12)

     [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
         Exchange Act (17 CFR 240.14d-2(b))

     [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
         Exchange Act (17 CFR 240.13e-4(c))

Item 7.01  Regulation FD Disclosure.
            ------------------------

     See the Press Release, Exhibit 99.1, attached hereto and incorporated
herein by reference.

Item 8.01 Other Events.
          ------------

     On March 7, 2006, we announced the execution of a Letter of Intent to
acquire JMST Systems, Inc.,  a Colorado corporation ("JMST").  JMST is an
original equipment manufacturer supplying leading biotechnology and
pharmaceutical firms.  Their primary product line is comprised of patented
optically based chemical detection instruments that are considered to be some
of the best performing instruments available and with their strong
intellectual property position in technology that will prove to be a
significant sustainable market advantage providing the industry with the next
level of detection capability will provide our Company with tremendous growth
potential. Please see the Press Release of March 7, 2006, which is attached
hereto and incorporated herein by reference.  See Item 9.01.

Item 9.01.  Financial Statements and Exhibits.
            ---------------------------------

Exhibit
Number                Description
------                -----------

99.1               Press Release of March 7, 2006.

                           SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this Current Report to be signed on its
behalf by the undersigned hereunto duly authorized.

                                               REFLECT SCIENTIFIC, INC.

Dated: 03/07/06                                 /s/ Kim Boyce
       --------                                ---------------------
                                               Kim Boyce
                                               President & Director